Featured Research

Higher disease rates in low sun latitudes

Multiple Articles


Populations in lower-sun latitudes show higher rates of multiple chronic diseases, largely attributed to reduced UVB-driven vitamin D synthesis and other non-vitamin-D biological pathways.


Cancer
UVB associated with lower age-adjusted cancer mortality across geographic regions.
Grant, W. B., & Garland, C. F. (2006). The association of solar ultraviolet B (UVB) with reducing risk of cancer: Multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Research, 26(4A), 2687–2699.

Breast Cancer
Lower UVB irradiance linked to higher breast cancer risk across 107 countries.
Mohr, S. B., Garland, C. F., Gorham, E. D., Grant, W. B., & Garland, F. C. (2008). Relationship between low ultraviolet B irradiance and higher breast cancer risk in 107 countries. The Breast Journal, 14(3), 255–260. https://doi.org/10.1111/j.1524-4741.2008.00576.x

Diabetes
Lower UVB and vitamin D status tied to higher diabetes incidence across 51 regions.
Mohr, S. B., Garland, C. F., Gorham, E. D., & Garland, F. C. (2008). The association between ultraviolet B irradiance, vitamin D status, and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia, 51, 1391–1398. https://doi.org/10.1007/s00125-008-1061-5

Multiple Sclerosis
Low sun exposure increases MS risk both directly and through vitamin D.
Hedström, A. K., Olsson, T., Kockum, I., Hillert, J., & Alfredsson, L. (2020). Low sun exposure increases multiple sclerosis risk both directly and indirectly. Journal of Neurology, 267, 1045–1052. https://doi.org/10.1007/s00415-019-09695-2

Stroke
Associated lower sunlight radiation with higher stroke incidence.
Kent, S. T., McClure, L. A., Judd, S. E., Howard, V. J., Crosson, W. L., Al-Hamdan, M. Z., & Kabagambe, E. K. (2013). Short- and long-term sunlight radiation and stroke incidence. Annals of Neurology, 73(1), 32–37. https://doi.org/10.1002/ana.23738

Depression
Found sunlight exposure correlated with mental health outcomes.
Wang, J., Wei, Z., Yao, N., Li, C., & Sun, L. (2023). Association between sunlight exposure and mental health: Evidence from a special population without sunlight in work. Risk Management and Healthcare Policy, 16, 1049–1057. https://doi.org/10.2147/RMHP.S401311

Alzheimer’s / Dementia
In a study of over 362,000 participants, linked less outdoor light time to higher dementia risk.
Ma, L. Z., Ma, Y. H., Ou, Y. N., Chen, S. D., Yang, L., Dong, Q., Cheng, W., Tan, L., & Yu, J. T. (2022). Time spent in outdoor light is associated with the risk of dementia: A prospective cohort study of 362,094 participants. BMC Medicine, 20(1), 132. https://doi.org/10.1186/s12916-022-02317-7

Obesity / Metabolic Health
Connected vitamin D status to cardio-metabolic risk factors.
Muldowney, S., Lucey, A. J., Paschos, G., Martinez, J. A., Bandarra, N., Thorsdottir, I., & Kiely, M. (2011). Relationships between vitamin D status and cardio-metabolic risk factors in young European adults. Annals of Nutrition and Metabolism, 58(2), 85–93. https://doi.org/10.1159/000323999

Osteoporosis
Found latitude affects hip fracture risk and seasonal variation in Sweden.
Odén, A., Kanis, J. A., McCloskey, E. V., & Johansson, H. (2014). The effect of latitude on the risk and seasonal variation in hip fracture in Sweden. Journal of Bone and Mineral Research, 29(10), 2217–2223. https://doi.org/10.1002/jbmr.2254

WHO / Sunlight Report
Mead, M. N. (2008). Benefits of sunlight: A bright spot for human health. Environmental Health Perspectives, 116(4), A160–A167. https://doi.org/10.1289/ehp.116-a160

Related Studies

Featured Research

Skin-directed Solius UVB light therapy increases vitamin D levels and alters intestinal microbiome and metabolome homeostasis

Frontiers in Microbiology

This mouse study tested whether Solius UVB light therapy could influence gut health, comparing vitamin D sufficient and deficient mice given either a single exposure or six repeated exposures over 14 days. Repeated exposures significantly increased vitamin D levels to match sufficient-diet controls without injury to the skin. Notably, repeated therapy significantly altered gut microbiota composition and fecal metabolome, especially in vitamin D–deficient mice, enriching bacteria linked to metabolic health and leanness while increasing beneficial compounds like short-chain fatty acids, bile acid derivatives, and tryptophan metabolites. Pathway analysis further suggested UVB exposure inhibited oxidative stress and tumor-related signaling while activating anti-inflammatory pathways. Serum metabolomic changes were much smaller than fecal changes, suggesting the effects were concentrated in the gut rather than just reflecting systemic responses. Overall, the study concludes Solius UVB therapy can be safely used to reshape gut microbial and metabolic profiles in a way that promotes gut health.

Featured Research

Skin-directed Solius UVB light therapy increases vitamin D levels and alters intestinal microbiome and metabolome homeostasis

Frontiers in Microbiology

This mouse study tested whether Solius UVB light therapy could influence gut health, comparing vitamin D sufficient and deficient mice given either a single exposure or six repeated exposures over 14 days. Repeated exposures significantly increased vitamin D levels to match sufficient-diet controls without injury to the skin. Notably, repeated therapy significantly altered gut microbiota composition and fecal metabolome, especially in vitamin D–deficient mice, enriching bacteria linked to metabolic health and leanness while increasing beneficial compounds like short-chain fatty acids, bile acid derivatives, and tryptophan metabolites. Pathway analysis further suggested UVB exposure inhibited oxidative stress and tumor-related signaling while activating anti-inflammatory pathways. Serum metabolomic changes were much smaller than fecal changes, suggesting the effects were concentrated in the gut rather than just reflecting systemic responses. Overall, the study concludes Solius UVB therapy can be safely used to reshape gut microbial and metabolic profiles in a way that promotes gut health.

Featured Research

Effectiveness of SOLIUS UVB Light System in Enhancing Serum 25-Hydroxyvitamin D Concentrations: A Randomized Controlled Trial

Anticancer Research

This randomized, placebo-controlled, clinical trial showed that the SOLIUS system effectively increased 25(OH)D concentrations in individuals with vitamin D deficiency or insufficiency, offering a safe solution for improving vitamin D status. The treatment group showed a significant increase in serum 25(OH)D concentrations, with an average increase of 10.2 ng/ml (p<0.01), compared to a decrease of 2.3 ng/ml in the control group.

Featured Research

Effectiveness of SOLIUS UVB Light System in Enhancing Serum 25-Hydroxyvitamin D Concentrations: A Randomized Controlled Trial

Anticancer Research

This randomized, placebo-controlled, clinical trial showed that the SOLIUS system effectively increased 25(OH)D concentrations in individuals with vitamin D deficiency or insufficiency, offering a safe solution for improving vitamin D status. The treatment group showed a significant increase in serum 25(OH)D concentrations, with an average increase of 10.2 ng/ml (p<0.01), compared to a decrease of 2.3 ng/ml in the control group.

Featured Research

Pre-Print: Risk–benefit balance of habitual ultraviolet exposure for cardiovascular, cancer, and skin cancer mortality

medRxiv

This large UK Biobank study of 419,007 adults found that higher habitual UV exposure was associated with significantly lower all-cause mortality, cardiovascular mortality, and non-skin cancer mortality, with clear dose-response trends. Critically, higher UV exposure showed no meaningful increase in skin cancer mortality. Counterfactual modeling quantified the trade-off directly: shifting the entire population to high UV exposure would prevent approximately 5,000 deaths from cardiovascular disease and internal cancers at the cost of only a few dozen additional skin cancer deaths - a net survival benefit ratio of roughly 100 to 1. Proteomic analysis in a 44,712-person subcohort identified the biological mechanisms as operating primarily through three non-vitamin D pathways - immunoregulatory, mucosal-barrier, and cardiorenal-neuroendocrine - confirming that the mortality benefits of UV exposure cannot be replicated by oral vitamin D supplementation. The authors conclude that current public health guidance, which frames sunlight primarily as a skin cancer hazard to be avoided, is inconsistent with the weight of evidence and warrants reappraisal. Limitations include the observational design, a White European-only cohort, and preprint status pending peer review. Builds upon this published research:

Featured Research

Pre-Print: Risk–benefit balance of habitual ultraviolet exposure for cardiovascular, cancer, and skin cancer mortality

medRxiv

This large UK Biobank study of 419,007 adults found that higher habitual UV exposure was associated with significantly lower all-cause mortality, cardiovascular mortality, and non-skin cancer mortality, with clear dose-response trends. Critically, higher UV exposure showed no meaningful increase in skin cancer mortality. Counterfactual modeling quantified the trade-off directly: shifting the entire population to high UV exposure would prevent approximately 5,000 deaths from cardiovascular disease and internal cancers at the cost of only a few dozen additional skin cancer deaths - a net survival benefit ratio of roughly 100 to 1. Proteomic analysis in a 44,712-person subcohort identified the biological mechanisms as operating primarily through three non-vitamin D pathways - immunoregulatory, mucosal-barrier, and cardiorenal-neuroendocrine - confirming that the mortality benefits of UV exposure cannot be replicated by oral vitamin D supplementation. The authors conclude that current public health guidance, which frames sunlight primarily as a skin cancer hazard to be avoided, is inconsistent with the weight of evidence and warrants reappraisal. Limitations include the observational design, a White European-only cohort, and preprint status pending peer review. Builds upon this published research:

Intertek logo

Solius is an FDA-cleared over-the-counter (OTC) UVB light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.

Intertek logo

Solius is an FDA-cleared over-the-counter (OTC) UVB light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.

Intertek logo

Solius is an FDA-cleared over-the-counter (OTC) UVB light panel intended to stimulate production of vitamin D in people 22 years and older.

Solius is clinically proven to stimulate the production of vitamin D. References to the benefits of sunlight, UVB light, and vitamin D are based upon published, peer-reviewed research. The Solius device is not intended to diagnose, treat, cure, or prevent disease, except for the indications for use described in the user manual for your applicable region. Solius does not provide specific medical advice to users. Users should seek advice from a qualified physician or healthcare provider. This website does not establish a doctor-patient relationship. For detailed product information please consult the User Manual prior to use. 

Solius® is a registered trademark of Solius Labs, Inc.
100 Ravine Lane NE, Suite 310, Bainbridge Island, WA 98110

© 2026 Solius Labs, Inc.